Teleflex (NYSE:TFX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Teleflex (NYSE:TFX) in the last three months. The table below provides a snapshot of their ...

Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday. The company posted quarterly earnings of $3.67 per share which beat the analyst consensus ...

Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021. TFX stock was trading at around $246 in early ...

Analysts' ratings for Teleflex (NYSE:TFX) over the last quarter vary from bullish to bearish, as provided by 4 analysts. In the table below, you'll find a summary of their recent ratings, revealing ...

Teleflex Incorporated (NYSE:TFX – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 earnings per share (EPS) estimates for shares of Teleflex in a research report issued to clients ...

Across the recent three months, 7 analysts have shared their insights on Teleflex (NYSE:TFX), expressing a variety of opinions spanning from bullish to bearish. The table below provides a concise ...

Teleflex Incorporated, a diversified medical device company, saw a 17% stock drop after Q3 results in late October. The stock now trades at under 13.5 EPS (non-GAAP) and at the equity's lowest ...

UroLift sales are likely to bottom out in Q2 or Q3 this year. Headwinds at Getinge could be accretive to Teleflex’s top- and bottom-line growth in 2025. Get real-time earnings alerts before the market ...

Investing.com - Citizens maintained its Market Perform rating on Teleflex (NYSE:TFX) following the company’s announcement of its NewCo business unit sale. The medical device company, currently trading ...